Related Experiment Videos
Laser surgery for malignant melanoma and superficial malignancies
The Australian and New Zealand Journal of Surgery
|December 1, 1978
Summary
The CO2 laser shows benefits for extensive superficial malignancies and soft tissue tumors, minimizing blood loss. However, it offers no advantage over traditional scalpels for primary malignant melanoma excision.
Area of Science:
- Oncology
- Surgical Technology
Background:
- Carbon dioxide (CO2) lasers are utilized in surgical oncology.
- Assessing the efficacy of CO2 laser in treating superficial malignancies is crucial.
Purpose of the Study:
- To evaluate the 18-month clinical experience with CO2 laser for treating malignant melanoma and other superficial malignancies.
- To compare CO2 laser surgery with traditional scalpel surgery.
Main Methods:
- A general assessment of CO2 laser advantages was conducted in 110 patients.
- A retrospective study compared laser and scalpel surgery in 39 patients undergoing wide excision and graft for primary malignant melanoma.
Main Results:
- The CO2 laser provided no specific advantages over the scalpel for primary malignant melanoma excision with lymph node dissection.
- The CO2 laser demonstrated advantages in treating extensive superficial malignancies, locally recurrent tumors, and soft tissue malignancies.
- Laser treatment minimized blood loss and achieved satisfactory lesion extirpation in specific cases.
Conclusions:
- The CO2 laser is a valuable tool for specific oncological applications, particularly extensive superficial and soft tissue malignancies.
- While not superior to scalpels for all malignant melanoma cases, the CO2 laser offers benefits in blood loss reduction and tumor extirpation in select situations.